LAWRENCE, Mass., Aug. 28, 2017 /PRNewswire/ -- NxStage Medical, Inc. (Nasdaq: NXTM), a leading medical technology company focused on advancing renal care, today announced that the U.S. Food and Drug ...
NxStage Medical Inc. of Lawrence has received U.S. Food and Drug Administration clearance to market its PureFlow SL product, a device that prepares high-purity dialysate from ordinary tap water in the ...
Home hemodialysis (HHD) may offer improved health and quality of life for patients with end-stage kidney disease (ESKD), which affects more than 800,000 Americans. [i] However, due to patient fears ...
LAWRENCE, Mass., Aug. 4, 2017 /PRNewswire/ -- NxStage Medical, Inc. (Nasdaq: NXTM), a leading medical technology company focused on advancing renal care, joins over one hundred NxStage patients in ...
SAN FRANCISCO (MarketWatch) -- NxStage Medical Inc. said late Wednesday it has received Food and Drug Administration 510(k) clearance to market its PureFlow SL product. This device is used to prepare ...
NxStage Medical, Inc.NXTM recently announced the receipt of CE mark for its NxGen Hemodialysis System, an innovative device with easier user interface and integrated blood pressure monitor system for ...
An impassioned and dedicated patient advocate, Hess has lived with End Stage Renal Disease (ESRD), or kidney failure, since the age of six. Hess was recognized during the AAKP 39 th Annual Patient ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback